Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome

Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome

Spliceosome mutations occur in approximately 50% of patients with myelodysplastic syndromes. Here, the authors show that tumour cells harbouring theS34F mutation in the U2AFspliceosome gene is sensitive to compounds that further perturb the spliceosome.

Saved in:
Bibliographic Details
Main Authors: Cara Lunn Shirai, Brian S. White, Manorama Tripathi, Roberto Tapia, James N. Ley, Matthew Ndonwi, Sanghyun Kim, Jin Shao, Alexa Carver, Borja Saez, Robert S. Fulton, Catrina Fronick, Michelle O’Laughlin, Chandraiah Lagisetti, Thomas R. Webb, Timothy A. Graubert, Matthew J. Walter
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Science
Q
Online Access:https://doaj.org/article/58561889db084efca98a8125161aeb78
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/58561889db084efca98a8125161aeb78

Similar Items